Long-term statin use associated with decreased risk of gallstones requiring surgery

Nov 10, 2009

Use of the cholesterol-lowering drugs statins for more than a year is associated with a reduced risk of having gallstones requiring surgery, according to a study in the November 11 issue of JAMA.

In developed countries, approximately 10 percent to 20 percent of white adults have gallstones, which can cause pain and complications. is a leading cause of illness and inpatient admission in western countries and represents a serious burden for health care systems worldwide. More than 700,000 cholecystectomies (removal of the gallbladder) are performed annually in the United States, according to background information in the article.

Gallstones are classified as either cholesterol (80 percent-90 percent) or pigment stones (10 percent-20 percent), with cholesterol stones formed on the basis of cholesterol-supersaturated bile. "Statins decrease hepatic [liver] cholesterol biosynthesis and may therefore lower the risk of cholesterol gallstones by reducing the cholesterol concentration in the bile. Data on this association in humans are scarce," the authors write.

Michael Bodmer, M.D., M.Sc., of University Hospital, Basel, Switzerland, and colleagues conducted a large long-term observational study to examine the association between statin use and the risk of developing gallstone disease followed by cholecystectomy. The study included data from between 1994 and 2008 from the UK-based General Practice Research Database. A total of 27,035 patients with cholecystectomy and 106,531 matched controls were identified, including 2,396 patients and 8,868 controls who had statin use.

The researchers found that compared with nonuse, current statin use (last prescription recorded within 90 days before the first-time diagnosis of the disease) was 1.0 percent for patients and 0.8 percent for controls for 1 to 4 prescriptions; 2.6 percent vs. 2.4 percent for 5 to 19 prescriptions, and 3.2 percent vs. 3.7 percent for 20 or more prescriptions.

"This large observational study provides evidence that patients with long-term statin use have a reduced risk of gallstone disease followed by cholecystectomy compared with patients without statin use. However, the odds ratio was not decreased for patients with short-term statin use but started to decrease after 5 prescriptions, reflecting approximately 1 to 1.5 years of treatment. The risk estimate was consistent across age and sex groups. Adjustment for important risk factors for gallstone disease did not materially alter the results," the researchers write.

The authors add that the observed risk reduction suggests a class effect for all statins, and that there was a tendency toward a lower risk of gallstone disease for high-dose statin use compared with low-dose exposure. A substantially increased gallstone risk with cholecystectomy was found for patients with high body mass indexes and for patients with estrogen use.

"Our findings may be of clinical relevance given that gallstone disease represents a major burden for health care systems," the researchers conclude.

More information: JAMA. 2009;302[18]:2001-2007.

Source: JAMA and Archives Journals (news : web)

Explore further: US cautiously optimistic after no new Ebola in 5 days

add to favorites email to friend print save as pdf

Related Stories

Study indicates cancer preventive effect for statins

May 05, 2009

The commonly used prescription statin drugs may have a protective effect in the prevention of liver cancer and lead to a reduction in the need for gallbladder removals, according to two studies published in Gastroenterology. As mil ...

Statins associated with lower risk of death from pneumonia

Oct 27, 2008

Individuals who take cholesterol-lowering statins before being hospitalized with pneumonia appear less likely to die within 90 days afterward, according to a report in the October 27 issue of Archives of Internal Medicine, one of ...

U of I study: exercise to avoid gallstones

Feb 13, 2008

A new University of Illinois study shows that exercise-trained mice get far fewer gallstones than sedentary mice and identifies potential mechanisms to explain why this occurs.

Tendon complications, though rare, linked to statins

Feb 28, 2008

Statins, the most effective treatment for lowering cholesterol, are widely used and have been demonstrated to be safe in large clinical trials. Although side effects are usually mild, more severe side effects, especially ...

Recommended for you

US cautiously optimistic after no new Ebola in 5 days

1 hour ago

With no new Ebola cases in five days, US authorities were cautious but hopeful Monday that the virus has been contained in the United States after a flawed response revealed shortcomings in the system.

Nigeria declared Ebola-free in 'spectacular success'

2 hours ago

Nigeria was declared Ebola-free on Monday in a "spectacular success" in the battle to contain the spread of a virus which is devastating Guinea, Sierra Leone and Liberia where more than 4,500 people have died.

EU says 'increased' effort needed to tackle Ebola

2 hours ago

European Union foreign ministers agreed Monday to step up efforts to contain Ebola to prevent it becoming a global threat, including ensuring proper care for international health workers.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

jerryd
not rated yet Nov 11, 2009


Satin can hurt too. Lipitor gave me fibromialgia systems, bad muscle pain, severe weakness, enough to make me bed ridden in just 3 weeks and Zocor gave me depression after 6 months. Stopping them solved the problems. So be very careful of any medicine you take. Just because it help a lot doesn't mean they help all.